|
Volumn 344, Issue 2, 2001, Pages 137-138
|
Treatment of renal-cell cancer by transplantation of allogeneic stem cells [1] (multiple letters)
a b c c d d e |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FLUDARABINE;
TUMOR ANTIGEN;
LIGASE;
PROTEIN;
TUMOR SUPPRESSOR PROTEIN;
UBIQUITIN PROTEIN LIGASE;
VHL PROTEIN, HUMAN;
VON HIPPEL LINDAU PROTEIN;
CHROMOSOME 3P;
DRUG MEGADOSE;
HUMAN;
KIDNEY CANCER;
LETTER;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
TUMOR SUPPRESSOR GENE;
VON HIPPEL LINDAU DISEASE;
ALLOTRANSPLANTATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
REMISSION;
ADENOCARCINOMA;
APOPTOSIS;
GENETICS;
METHODOLOGY;
MUTATION;
ANIMAL;
GRAFT VERSUS HOST REACTION;
HISTOCOMPATIBILITY;
HISTOCOMPATIBILITY TEST;
IMMUNOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
T LYMPHOCYTE;
CARCINOMA, RENAL CELL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
KIDNEY NEOPLASMS;
REMISSION, SPONTANEOUS;
TRANSPLANTATION, HOMOLOGOUS;
ADENOCARCINOMA, CLEAR CELL;
APOPTOSIS;
GENES, TUMOR SUPPRESSOR;
LIGASES;
MUTATION;
PROTEINS;
REMISSION INDUCTION;
TUMOR SUPPRESSOR PROTEINS;
UBIQUITIN-PROTEIN LIGASES;
VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;
ANIMALS;
GRAFT VS HOST DISEASE;
GRAFT VS HOST REACTION;
HISTOCOMPATIBILITY TESTING;
T-LYMPHOCYTES;
TRANSPLANTATION CHIMERA;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION IMMUNOLOGY;
|
EID: 0035843265
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200101113440211 Document Type: Letter |
Times cited : (9)
|
References (0)
|